Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Marsh & McLennan Companies, Inc., doing business as Marsh McLennan, files reports with the US Securities and Exchange Commission as a public company with common stock listed on the New York Stock Exchange. This SEC filings page for MMC provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other filings that document material events, governance changes and financial reporting updates.
Recent Form 8-K filings illustrate the types of information Marsh McLennan reports. One filing describes amendments and restatements of the company’s bylaws, noting updates to align with changes in the Delaware General Corporation Law, revisions to advance notice provisions for director nominations and stockholder proposals, clarification of voting standards for matters submitted to stockholders, and clarification of the authority of the chair of stockholder meetings. Other 8-K filings disclose quarterly financial results, conference calls to discuss those results, and board-level changes such as the appointment of an independent director to the Board and Audit Committee.
Filings also show details about Marsh McLennan’s capital structure and listing status, including the registration of its common stock, par value $1.00 per share, and the trading symbols under which it is listed on the New York Stock Exchange. Investors can review these filings to understand how Marsh McLennan communicates material events, corporate governance changes and financial information.
On Stock Titan, Marsh McLennan’s SEC filings are paired with AI-powered tools that can help explain the contents of lengthy documents, highlight key sections, and surface items such as current reports, annual and quarterly reports, and disclosures about governance or board changes. This makes it easier to navigate Marsh McLennan’s regulatory history, track updates over time, and connect specific filings to news and other public communications about the company.
Marsh & McLennan Companies, Inc. has adopted amended and restated bylaws, effective January 14, 2026. The revisions update various provisions to align with recent changes to the Delaware General Corporation Law, including rules on stockholder lists and quorum for board committee meetings.
The bylaws also tighten and clarify advance notice procedures for director nominations and other stockholder proposals, including disclosure requirements, limits on the number of nominees, and alignment with the universal proxy rules under Rule 14a-19. In addition, they clarify the voting standard for matters submitted to stockholders and the authority of the chair at stockholder meetings, along with other conforming and clarifying changes.
Marsh & McLennan Companies, Inc. president and CEO exercised stock options and sold shares of the company on 12/01/2025. He exercised stock options covering 21,079 shares of common stock at an exercise price of
On the same day, he sold 21,079 shares of Marsh & McLennan common stock at a sale price of
MMC has a notice of proposed insider sales under Rule 144 covering 21,079 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $3,841,015.38. The filing states that 489,909,683 shares of this class were outstanding.
The seller acquired 21,079 common shares on 12/01/2025 via an option originally granted on 05/01/2016, paid for in cash. Over the prior three months, the same seller disposed of 21,079 common shares on 09/02/2025, generating gross proceeds of $4,334,896.35.
Marsh & McLennan Companies (MMC) director reports routine equity awards. A company director filed a Form 4 disclosing changes in derivative securities tied to MMC common stock. On 11/14/2025, the director reported 426.84 restricted stock units under the Directors Stock Compensation Plan, acquired through dividend equivalents that convert into MMC common stock on a 1-for-1 basis. On 11/15/2025, the director acquired an additional 225.07 restricted stock units in connection with director fees under the same plan. Following these transactions, the director beneficially owned 87,649.88 restricted stock units on a direct basis.
Marsh & McLennan Companies, Inc. (MMC) reported an insider equity transaction by a company director on a Form 4. On 11/14/2025, the director acquired 75.99 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, coded as transaction type "J" and described as dividend equivalents credited to the reporting person's account. Each restricted stock unit converts into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, the director beneficially owned 15,563.68 derivative securities in the form of restricted stock units, held directly.
Marsh & McLennan Companies, Inc. (MMC)11/14/2025, the director acquired 96.91 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, recorded as a transaction code J.
The filing shows these units were credited as dividend equivalents to the director’s account, meaning additional units were granted in lieu of cash dividends. Each restricted stock unit converts into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, the director beneficially owned 19,849.64 derivative securities (restricted stock units) held directly, with a reported derivative security price of $183.435.
Marsh & McLennan Companies director reports additional stock units. A director of MARSH & MCLENNAN COMPANIES, INC. (MMC) reported an acquisition of derivative securities on 11/14/2025. The filing shows the director received 37.37 restricted stock units through dividend equivalents credited under the Marsh & McLennan Companies Directors Stock Compensation Plan. These units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, the director beneficially owned 7,653.6 restricted stock units, held in direct ownership.
Marsh & McLennan Companies (MMC) reported a Form 4 filing showing a director’s routine equity compensation activity. On 11/14/2025, the director acquired 50.26 restricted stock units credited as dividend equivalents under the Marsh & McLennan Companies Directors Stock Compensation Plan. Each unit converts into one share of Marsh & McLennan common stock.
On 11/15/2025, the same director acquired an additional 197.78 restricted stock units in connection with director fees under the same plan. Following these transactions, the director beneficially owns 10,491.67 restricted stock units, held directly.
Marsh & McLennan Companies (MMC) reported a director equity transaction on Form 4. On 11/14/2025, the director had 34.22 restricted stock units under the Directors Stock Compensation Plan credited as dividend equivalents, each convertible into one share of common stock. On 11/15/2025, the director acquired an additional 148.34 restricted stock units in connection with director fees under the same plan. The reported prices were $183.435 and $183.28 per unit, and following these transactions the director directly beneficially owned 7,157.45 restricted stock units.
Marsh & McLennan Companies (MMC) director reports small equity award. A company director filed a Form 4 showing the acquisition of 4.58 restricted stock units on 11/14/2025 under the Marsh & McLennan Companies Directors Stock Compensation Plan. These units were credited as dividend equivalents, meaning the director received additional units in lieu of cash dividends. Each restricted stock unit converts into one share of Marsh & McLennan common stock. The filing reports a price of $183.435 per unit and shows the director now beneficially owns 938.25 derivative securities in this form, held directly. This reflects routine director equity compensation rather than a market purchase or sale.
FAQ
What is the current stock price of Marsh & Mclennan (MMC)?
What is the market cap of Marsh & Mclennan (MMC)?
